Kieran O'Kane, Chief Commercial Officer at BIODESIX INC (BDSX), sold 468 shares at $1.48 ($693) on 2024-05-09, disclosed to the SEC on 2024-05-10.
Open-market sale of $693 BDSX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BDSX | SELL | 2026-01-20 | $2K | — | Filing → |
| BDSX | SELL | 2025-11-13 | $191 | — | Filing → |
| BDSX | SELL | 2025-08-14 | $200 | — | Filing → |